265P Phase II study of DHP107 oral paclitaxel compared to IV paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer (MBC): Opera (NCT03326102)
| Autor: | Rugo, H.S., Pluard, T.J., Sharma, P., Melisko, M., Al-Jazayrly, G., Ji, Y., Vidula, N., Ellerton, J.A., Smakal, M., Zimovjanova, M., Weng, D., Yoon, K.E., Cho, H.J. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S658-S658 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|